Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation

Hiromichi Yamane1 Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, JapanCorrespondence[email protected]

Nobuaki Ochi1 Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan

Masayuki Yasugi2 Department of Respiratory Medicine, National Hospital Organization Fukuyama Medical Center, Fukuyama, Japan

Takayuki Tabayashi1 Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan

Tomoko Yamagishi1 Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan

Yasumasa Monobe3 Department of Pathology, Kawasaki Medical School Kawasaki Hospital, Okayama, Japan

Akiko Hisamoto4 Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan

Katsuyuki Kiura4 Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan

Nagio Takigawa1 Department of General Internal Medicine 4, Kawasaki Medical School, Okayama, Japan

Your download is now in progress and you may close this window